RARE — Ultragenyx Pharmaceutical
Median target
$28
calls from the last 12 months
Implied return
+93.1%
median target vs. price
Coverage
24 analysts · 31 calls
updated in the last 12 months
Consensus
14/10/0+14 net
Buy / Hold / Sell
Which analysts are behind RARE's consensus?
See every current rating, price target and the analysts' track records for Ultragenyx Pharmaceutical — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 24 analysts with calls on RARE updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
RARE elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-15 | Insiders | Huizenga Theodore AlanSVP, Chief Accounting Of | Insider sale | 1.3K sh @ $13.57 · planned trade | $17K |
| 2026-09-03 | Insiders | Huizenga Theodore AlanSVP, Chief Accounting Of | Insider sale | 161 sh @ $13.99 | $2K |
| 2026-08-03 | Insiders | Horn HowardChief Financial Officer | Insider sale | 4.7K sh @ $24.92 · planned trade | $117K |
| 2026-08-03 | Insiders | Parschauer Karah HerdmanEVP and Chief Legal Offi | Insider sale | 1.9K sh @ $24.92 · planned trade | $47K |
| 2026-02-18 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade -29.0%, vs market -40.3% | $1K–$15K |
| 2025-08-08 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade -47.3%, vs market -67.9% | $1K–$15K |
| 2025-07-15 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade -46.7%, vs market -70.1% | $1K–$15K |
| 2025-04-08 | Executive | Trump, Donald JPresident | Purchase | Ultragenyx Pharmaceutical Inc. | $15,001 - $500,004 |
More: congressional trades on RARE · insider activity · executive branch · trending